Published: 6 June 2024
Publications
Quarterly summary of recent safety communications
Published: 6 June 2024
Prescriber Update 45(2): 36
June 2024
The table below is a summary of recent safety communications for
healthcare professionals and consumers. Click on a specific topic to
go to the communication.
| Date |
Communication |
Topic |
| 17/05/2024 |
Dear Healthcare Professional Letter |
Phenergan
(promethazine): Restriction of oral formulation use in children
less than 6 years of age (PDF, 4 pages, 88KB) |
| 13/05/2024 |
Alert |
Promethazine (oral): Do not use in children under 6 years of
age due to the risk of psychiatric and central nervous system
side effects |
| 02/05/2024 |
Dear Healthcare Professional Letter |
Paracetamol Kabi – shortage of 1000mg/100mL solution for injection
vial and temporary supply of UK-labelled product (PDF, 2
pages, 115 KB) |
| 24/04/2024 |
Dear Healthcare Professional Letter |
Oramorph
– Supply of provisionally approved Oramorph 10mg/5mL to address
supply shortage of morphine hydrochloride oral solution
(PDF, 1 page, 242 KB) |
| 08/04/2024 |
Alert |
Do not use NaturaCoco Moisturising Cream or Dok Apo Moisturiser
Soothing Cream |
| 08/04/2024 |
Monitoring |
Calcium channel blockers and the possible risk of new-onset
eczema |
| 05/03/2024 |
Dear Healthcare Professional Letter |
Dexmedetomidine Viatris 200mcg/2mL concentrate for infusion
– labelling exemption to allow supply of Dexmedetomidine Mylan
from Australia (PDF, 1 page, 204 KB) |
| 05/03/2024 |
Dear Healthcare Professional Letter |
Rocuronium bromide (Hameln) – supply of Croatian/Slovenian-labelled
Rocuronium bromide (Hameln) solution for injection 10mg/mL
(PDF, 3 pages, 427 KB) |
| February 2024 |
Dear Healthcare Professional Letter |
Coversyl – Changes to 4mg tablet appearance and changes to packaging
(PDF, 4 pages, 457 KB) |
